Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in PROTAGONIST THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 107,437 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $11.3M as of 2026-Q1. The position was increased (+2.8% shares). PTGX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$11.3M
Current Shares
107,437
Total Value Change
-$1.5M
Total Shares Change
-262,518
Other major holders of PTGX: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., CAPITAL FUND MANAGEMENT S.A.
Increased |
| 107,437 |
+2.8% |
| $11.3M |
| 0.0% |
| $91.30 |
29 |
| 2025-Q4 | Decreased | 104,528 | -5.2% | $9.1M | 0.0% | $87.26 | 0 |
| 2025-Q3 | Decreased | 110,229 | -54.7% | $7.3M | 0.0% | $65.14 | 0 |
| 2025-Q2 | Increased | 243,373 | +16.6% | $13.5M | 0.0% | $55.69 | 32 |
| 2025-Q1 | Decreased | 208,756 | -27.5% | $10.1M | 0.0% | $48.88 | 0 |
| 2024-Q4 | Decreased | 287,911 | -21.8% | $11.1M | 0.0% | $38.51 | 0 |
| 2024-Q3 | Decreased | 368,132 | -0.5% | $16.6M | 0.0% | $44.56 | 0 |
| 2024-Q2 | Increased | 369,955 | +10.3% | $12.8M | 0.0% | $34.65 | 31 |